Skip to content

Prevention of lymphoedema after clearance by external compression

Prevention of lymphoedema after axillary clearance by early external compression: a multicentre randomised interventional treatment trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN92355292
Enrollment
270
Registered
2010-10-28
Start date
2010-10-01
Completion date
Unknown
Last updated
2020-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topic: National Cancer Research Network

Interventions

Intervention: Application of a graduated compression garment to the affected arm together with standard management for 12 months. Control: Standard man

Sponsors

University Hospital of South Manchester (UK)
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Women aged 18 - 90 years 2. Early breast cancer (no evidence of metastatic disease by local screening procedures), scheduled to undergo axillary node clearance 3. Consented to pre-surgical arm measurements by perometer and develop arm volume increases of 4 - 8.9% within 6 months after surgery 4. Willing to attend for follow-up visits per the trial schedule 5. Written informed consent to enter the PLACE trial

Exclusion criteria

Exclusion criteria: 1. Any patients with no pre-surgical baseline measurements 2. Known distant metastasis 3. Inoperable breast cancer (T4 category or distant metastasis) 4. Node negative not undergoing axillary clearance 5. Previous axillary radiotherapy 6. Past history of breast/chest wall radiotherapy 7. Previous axillary clearance, either unilateral or bilateral 8. Participation in another clinical trial of local therapy that may affect the results obtained in this study 9. Pregnancy

Design outcomes

Primary

MeasureTime frame
Incidence of lymphoedema (greater than 10% arm volume increase compared to contralateral arm) at 2 and 5 years after axillary node clearance (assessed by perometer scanning).

Secondary

MeasureTime frame
1. Quality of life (TOI and FACT B+4) 2. Costs of individual strategies (EQ5D utility measures) 3. Incidence of infection/lymphangitis at 2 years after surgery 4. Arm movement

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026